Subscribe
Sign in
Home
Podcast
Notes
Archive
Leaderboard
About
Latest
Top
Discussions
Abbott’s New MRD Test and More from ESMO, ASHG: Newsletter Oct. 28
Roche touts Axelios launch progress, MGI Tech reports Q3, Qiagen goes private, BMS Licenses Tempus AI oncology data, and more.
16 hrs ago
•
Andrew P. Han
Roche Touts Axelios Progress, Twist Bio Partnership in Q3 Business Update
Roche said it has received orders of approximately 30 instruments, one-third of its target of 100 instruments in the first year.
Oct 27
•
Andrew P. Han
MGI Tech Q3 Revenues Rise 2 Percent
The Chinese sequencing and lab automation company reported 783.7 million yuan ($117.6 million) in third-quarter revenue, as its net loss narrowed.
Oct 27
•
Andrew P. Han
Bristol Myers Squibb Licenses Tempus AI Oncology Data
BMS also will get access to Tempus' Lens Platform. Financial details for the expanded partnership were not disclosed.
Oct 23
•
Andrew P. Han
Qiagen Agrees to Be Taken Private in $12.1B Deal
The all-cash offer from Swedish private equity firm EQT is a 40 percent premium to Qiagen's price before takeover reports. Closing is expected in…
Oct 22
•
Andrew P. Han
1
For Genomics Companies, a Silver Lining in the Cloud: Newsletter Oct. 21
Qiagen for sale? Announcements from ASHG, Myriad sells prenatal testing to Labcorp, Nvidia launches new AI protein design model, and more.
Oct 21
•
Andrew P. Han
Abbott's Cologuard Plus Receives European CE Mark
The company said it plans to roll out the stool-based colorectal cancer test in select markets, but did not provide any details.
Oct 21
•
Andrew P. Han
Takara Bio, SPT Labtech Partner on Automated NGS Library Prep
The first product with an automated workflow will be the SMART-Seq mRNA Long Read Extended kit, slated to ship in January 2027.
Oct 20
•
Andrew P. Han
Myriad Genetics to Sell Prenatal Testing Business to Labcorp for $210M
The deal includes Myriad's Prequel and Foresight Prenatal tests and is expected to close by early 2027, subject to regulatory clearance.
Oct 20
•
Andrew P. Han
PacBio May Discount Sequencers to Gain Access to Data They Generate
A new strategic partnership with Google’s Verily Health sets up data as a future revenue source for the long-read sequencing technology provider.
Oct 19
•
Andrew P. Han
UK Biobank 80K-Sample Immune Study Taps Ultima Sequencing, BD Single-Cell Platform
The immune profiling project, led by UK-based IMU Biosciences, could expand to all 500,000 UK Biobank participants, the companies said.
Oct 19
•
Andrew P. Han
1
Epigenetics, Methylation, and Aging, With OHSU’s Andrew Adey
Ep. 15: Adey, a methylation researcher, explains how scientsists are using new technologies to build on theories about cell identity and aging that date…
Oct 16
•
Andrew P. Han
1
50:16
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
